Causal Flows
are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators
and regulons
. In the causal flow, a mutation
may causally activate or deactivate a downstream regulator which then might up- down-regulates a regulon that contains genes with similar expression profiles and binding sites.
Causal Mechanistic Flows regulated by Mutation MLL2_code_potential_somatic
ID | Mutation | Role | Regulator | Role | Regulon | # downstream regulons | # diffexp regulons | Drugs |
---|---|---|---|---|---|---|---|---|
CMF-26550 | MLL2 | down-regulates | IRF9 | activates | R-1457 | 15 | 4 | Drugs (2) |
CMF-26551 | MLL2 | down-regulates | IRF9 | activates | R-1446 | 15 | 4 | Drugs (12) Regulator Drugs (0)Regulon Drugs (12)OPROZOMIB, IXAZOMIB, MARIZOMIB, NIVOCASAN, BORTEZOMIB, EMRICASAN, EMAPUNIL, BELNACASAN, IXAZOMIB CITRATE, ALEMTUZUMAB, ONO-2952, CARFILZOMIB |
CMF-26553 | MLL2 | down-regulates | IRF1 | activates | R-115 | 25 | 1 | Drugs (13) Regulator Drugs (0)Regulon Drugs (13)OPROZOMIB, INTERFERON GAMMA-1B, IXAZOMIB, MARIZOMIB, NIVOCASAN, BORTEZOMIB, EMRICASAN, EMAPUNIL, BELNACASAN, IXAZOMIB CITRATE, ALEMTUZUMAB, ONO-2952, CARFILZOMIB |
CMF-26554 | MLL2 | down-regulates | FOS | activates | R-3398 | 6 | 1 | Drugs (7) Regulator Drugs (0)Regulon Drugs (7)SCH-708980, CANAKINUMAB, RILONACEPT, GEVOKIZUMAB, LUTIKIZUMAB, GLEMBATUMUMAB VEDOTIN, GLEMBATUMUMAB |